Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nymox Pharmaceutical Corp (NYMXF)
:NYMXF
RESEARCH TOOLSreports
Holding NYMXF?
Track your performance easily
NYMXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $1.40
Previous CloseN/A
Volume2.20K
Average Volume (3M)38.08K
Market Cap
$11.79M
Enterprise ValueN/A
Total Cash (Recent Filing)$2.02M
Total Debt (Recent Filing)$930.83K
Price to Earnings (P/E)―
Beta-544.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding93,540,140
10 Day Avg. Volume46,624
30 Day Avg. Volume38,079
Standard Deviation22.01
R-Squared0.00048
Alpha2.78
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nymox Pharmaceutical News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors
NYMXF FAQ
What was Nymox Pharmaceutical Corp’s price range in the past 12 months?
Nymox Pharmaceutical Corp lowest stock price was <$0.01 and its highest was $1.40 in the past 12 months.
What is Nymox Pharmaceutical Corp’s market cap?
Nymox Pharmaceutical Corp’s market cap is $11.79M.
When is Nymox Pharmaceutical Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nymox Pharmaceutical Corp’s earnings last quarter?
Currently, no data Available
Is Nymox Pharmaceutical Corp overvalued?
According to Wall Street analysts Nymox Pharmaceutical Corp’s price is currently Overvalued.
Does Nymox Pharmaceutical Corp pay dividends?
Nymox Pharmaceutical Corp does not currently pay dividends.
What is Nymox Pharmaceutical Corp’s EPS estimate?
Nymox Pharmaceutical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nymox Pharmaceutical Corp have?
Nymox Pharmaceutical Corp has 93,540,140 shares outstanding.
What happened to Nymox Pharmaceutical Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nymox Pharmaceutical Corp?
Currently, no hedge funds are holding shares in NYMXF
---
Company Description
Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
---
Technical Analysis
---